title: The need for rigorous evidence on medication use in preterm infants: is it time for a neonatal rule?
authors.affiliation: Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts 02111, USA. jdavis@tuftsmedicalcenter.org
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Davis
authors.forename: Edward M
authors.initials: EM
authors.lastname: Connor
authors.forename: Alastair J J
authors.initials: AJ
authors.lastname: Wood
mesh_terms: D055808:Drug Discovery; D004345:Drug Industry; D055317:Evidence-Based Practice; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007234:Infant, Premature; D007363:Intensive Care Units, Neonatal; D056687:Off-Label Use; D047928:Premature Birth; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014486:United States Food and Drug Administration